Webinar on Transitioning from Use of Decontaminated Disposable Respirators

Join us on Tuesday, April 27, at 12:00 p.m. ET for the next webinar in the series.

If your email program has trouble displaying this email, view as a webpage. Join Us: Webinar on Transitioning from Use of Decontaminated Disposable Respirators The U.S. Food and Drug Administration (FDA) will host a webinar to share information and answer questions about transitioning from use of decontaminated disposable respirators. Specifically, the FDA will present information about the April 9, 2021 FDA Recommends Transition from Use of Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities. This webinar is part of the series on Respirators and Other Personal Protective Equipment (PPE) for Health Care Personnel Use during the COVID-19 Pandemic. Date: Tuesday, April 27, 2021 Time: 12:00-1:00 p.m. ET Registration: No registration required. View the webinar details for call-in information. View the Webinar Details Representatives from the FDA, the Centers for Disease Control and Prevention's (CDC) National Institute for Occupational Safety and Health (NIOSH), and the Occupational Safety and Health Administration (OSHA) will answer your questions about the recommendation to transition from use of decontaminated disposable respirators. If you are unable to attend the live webinar, the recording and transcript will be available on FDA.gov after the live event. SAVE THE DATE: The FDA hosts a series of webinars to share information and answer your questions about respirators and other personal protective equipment (PPE). The FDA will announce additional webinar dates in May. Previous Webinars in This Series Recordings, printable slides, and transcripts from previous webinars in this series are available on the FDA's website. Questions? If you have questions, please contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA